A case of cannabinoid hyperemesis syndrome with Heliobacter pylori and preeclampsia during pregnancy

References

• Allen JH, de Moore GM, Heddle R, Twartz JC. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. Gut. 2004;53:1566–1570.
   PubMed Web of Science ®Google Scholar
• Donnino MW, Cocchi MN, Miller J, Fisher J. Cannabinoid hyperemesis: a case series. J Emerg Med. 2011;40:e63–e66.
   PubMedGoogle Scholar
• Nicolson SE, Denysenko L, Mulcare JL, Vito JP, Chabon B. Cannabinoid hyperemesis syndrome: a case series and review of previous reports. Psychosomatics. 2012;53:212–219.
   PubMed Web of Science ®Google Scholar
• Simonetto DA, Oxentenko AS, Herman ML, Szostek JH. Cannabinoid hyperemesis: a case series of 98 patients. Mayo Clin Proc. 2012;87:114–119.
   PubMed Web of Science ®Google Scholar
• Sun S, Zimmermann AE. Cannabinoid hyperemesis syndrome. Hosp Pharm. 2013;48:650–655.
   PubMedGoogle Scholar
• Sontineni SP, Chaudhary S, Sontineni V, Lanspa SJ. Cannabinoid hyperemesis syndrome: clinical diagnosis of an underrecognised manifestation of chronic cannabis abuse. World J Gastroenterol. 2009;15:1264–1256.
   PubMed Web of Science ®Google Scholar
• Blumentrath CG, Dohrmann B, Ewald N. Cannabinoid hyperemesis and the cyclic vomiting syndrome in adults: recognition, diagnosis, acute and long-term treatment. Ger Med Sci. 2017;15:Doc06.
   PubMedGoogle Scholar
• Grooten IJ, Roseboom TJ, Painter RC. Barriers and challenges in hyperemesis gravidarum research. Nutr Metab Insights. 2015;8(Suppl 1):33–39.
   PubMed Web of Science ®Google Scholar
• Mitchell-Jones N, Gallos I, Farren J, Tobias A, Bottomley C, Bourne T. Psychological morbidity associated with hyperemesis gravidarum; a systematic review and meta-analysis. BJOG 2016;124(1):20–30.
   PubMed Web of Science ®Google Scholar
• Practice Bulletin No. 153: Nausea and vomiting of pregnancy. Obstet Gynecol. 2015;126:e12–e24.
   PubMed Web of Science ®Google Scholar
• Argamany JR, Reveles KR, Duhon B. Synthetic cannabinoid hyperemesis resulting in rhabdomyolysis and acute renal failure. Am J Emerg Med. 2016;34:765.e1–e2.
   Web of Science ®Google Scholar
• Committee Opinion No. 637: Marijuana use during pregnancy and lactation. Obstet Gynecol. 2015;126:234–238.
   PubMed Web of Science ®Google Scholar
• Chabarria KC, Diana A. Racusin, Kathleen M. Antony, Maike Kahr, Melissa A, Suter, Joan M. Mastrobattista , et al. Marijuana use and its effects in pregnancy. Am J Obstet Gynecol. 2016;215(4):506.e1–7.
   PubMed Web of Science ®Google Scholar
• McPartland JM, Duncan M, Di Marzo V, Pertwee RG. Are cannabidiol and Delta(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review. Br J Pharmacol. 2015;172:737–753.
   PubMed Web of Science ®Google Scholar
• Howlett AC. Efficacy in CB1 receptor-mediated signal transduction. Br J Pharmacol. 2004;142:1209–1218.
   PubMed Web of Science ®Google Scholar
• Howlett AC, Breivogel CS, Childers SR, Deadwyler SA, Hampson RE, Porrino LJ. Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology. 2004;47(Suppl 1):345–358.
   PubMed Web of Science ®Google Scholar
• Pacher P, Batkai S, Kunos G. Cardiovascular pharmacology of cannabinoids. Handb Exp Pharmacol. 2005;(168):599–625.
   PubMedGoogle Scholar
• Parfieniuk A, Flisiak R. Role of cannabinoids in chronic liver diseases. World J Gastroenterol. 2008;14:6109–6114.
   PubMed Web of Science ®Google Scholar
• Pertwee RG. Cannabinoids and the gastrointestinal tract. Gut. 2001;48:859–867.
   PubMed Web of Science ®Google Scholar
• Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev. 2002;54:161–202.
   PubMed Web of Science ®Google Scholar
• Van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K, et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science. 2005;310:329–332.
   PubMed Web of Science ®Google Scholar
• Van Sickle MD, Oland LD, Ho W, Hillard CJ, Mackie K, Davison JS, Sharkey KA. Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret. Gastroenterology. 2001;121:767–774.
   PubMed Web of Science ®Google Scholar
• Tafelski S, Hauser W, Schafer M. Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting—a systematic review of systematic reviews. Schmerz. 2016;30:14–24.
   PubMed Web of Science ®Google Scholar
• Smith LA, Azariah F, Lavender VT, Stoner NS, Bettiol S. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy. Cochrane Database Syst Rev. 2015;(11):CD009464.
   PubMed Web of Science ®Google Scholar
• Rock EM, Parker LA. Cannabinoids as potential treatment for chemotherapy-induced nausea and vomiting. Front Pharmacol. 2016;7:221.
   PubMed Web of Science ®Google Scholar
• Pertwee RG. Pharmacological actions of cannabinoids. Handb Exp Pharmacol. 2005;(168):1–51.
   PubMedGoogle Scholar
• DiPatrizio NV. Endocannabinoids in the gut. Cannabis Cannabinoid Res. 2016;1:67–77.
   PubMedGoogle Scholar
• Izzo AA, Sharkey KA. Cannabinoids and the gut: new developments and emerging concepts. Pharmacol Ther. 2010;126:21–38.
   PubMed Web of Science ®Google Scholar
• Richards JR. Cannabinoid hypermesis syndrome: a disorder of the HPA axis and sympathetic nervous system? Med Hypotheses. 2017;103:90–95.
   PubMed Web of Science ®Google Scholar
• Buyukbese Sarsu S. Unusual side effect of cannabis use: acute abdomen due to duodenal perforation. Int J Emerg Med. 2016;9:18.
   PubMed Web of Science ®Google Scholar
• Sevinc MM, Kinaci E, Bayrak S, Yardimci AH, Cakar E, Bektas H. Extraordinary cause of acute gastric dilatation and hepatic portal venous gas: chronic use of synthetic cannabinoid. World J Gastroenterol. 2015:21:10704–10708.
   PubMed Web of Science ®Google Scholar
• Swanson M, Epperly T. Vomiting, abdominal pain, compulsive bathing—Dx? J Fam Pract. 2014;63:257–259.
   PubMed Web of Science ®Google Scholar
• Mohammed F, Panchoo K, Bartholemew M, Maharaj D. Compulsive showering and marijuana use—the cannabis hyperemisis syndrome. Am J Case Rep. 2013;14:326–328.
   PubMedGoogle Scholar
• Sorensen CJ, DeSanto K, Borgelt L, Phillips KT, Monte AA. Cannabinoid hyperemesis syndrome: diagnosis, pathophysiology, and treatment—a systematic review. J Med Toxicol. 2017;13:71–87.
   PubMed Web of Science ®Google Scholar
• McParlin C, Duncan M, Di Marzo V, Pertwee RG. Treatments for hyperemesis gravidarum and nausea and vomiting in pregnancy: a systematic review. JAMA. 2016;316:1392–1401.
   PubMed Web of Science ®Google Scholar
• Roberson EK, Patrick WK, Hurwitz EL. Marijuana use and maternal experiences of severe nausea during pregnancy in Hawai'i. Hawaii J Med Public Health. 2014;73:283–287.
   PubMedGoogle Scholar
• Wu CS, Jew CP, Lu HC. Lasting impacts of prenatal cannabis exposure and the role of endogenous cannabinoids in the developing brain. Future Neurol. 2011;6:459–480.
   PubMedGoogle Scholar
• Alpar A, Di Marzo V, Harkany T. At the tip of an iceberg: prenatal marijuana and its possible relation to neuropsychiatric outcome in the offspring. Biol Psychiatry. 2016;79:e33–e45.
   PubMed Web of Science ®Google Scholar
• Andrews KH, Bracero LA. Cannabinoid hyperemesis syndrome during pregnancy: a case report. J Reprod Med. 2015;60:430–432.
   PubMed Web of Science ®Google Scholar
• Alaniz VI, Liss J, Metz TD, Stickrath E. Cannabinoid hyperemesis syndrome: a cause of refractory nausea and vomiting in pregnancy. Obstet Gynecol. 2015;125:1484–1486.
   PubMed Web of Science ®Google Scholar
• Schmid SM, Lapaire O, Huang DJ, Jürgens FE, Güth U. Cannabinoid hyperemesis syndrome: an underreported entity causing nausea and vomiting of pregnancy. Arch Gynecol Obstet. 2011;284:1095–1097.
   PubMed Web of Science ®Google Scholar
• Gunn JK, Rosales CB, Center KE, Nuñez A, Gibson SJ, Christ C, et al. Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open. 2016;6:e009986.
   PubMed Web of Science ®Google Scholar
• Brown SJ, Mensah FK, Ah Kit J, Stuart-Butler D, Glover K, Leane C, et al. Use of cannabis during pregnancy and birth outcomes in an Aboriginal birth cohort: a cross-sectional, population-based study. BMJ Open. 2016;6:e010286.
   PubMed Web of Science ®Google Scholar
• Volkow ND, Compton WM, Wargo EM. The risks of marijuana use during pregnancy. JAMA. 2017;317:129–130.
   PubMed Web of Science ®Google Scholar
• Rom S, Persidsky Y. Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation. J Neuroimmune Pharmacol. 2013;8:608–620.
   PubMed Web of Science ®Google Scholar
• Yusifzade K, et al. The protective role of anandamide in mesenteric ischemia reperfusion injury in guinea pig. Bratisl Lek Listy. 2009;110:379–384.
   PubMed Web of Science ®Google Scholar
• Wang PF, Jiang LS, Bu J, Huang XJ, Song W, Du YP, He B. Cannabinoid-2 receptor activation protects against infarct and ischemia-reperfusion heart injury. J Cardiovasc Pharmacol. 2012;59:301–307.
   PubMed Web of Science ®Google Scholar
• Pacher P, Mackie K. Interplay of cannabinoid 2 (CB2) receptors with nitric oxide synthases, oxidative and nitrative stress, and cell death during remote neurodegeneration. J Mol Med (Berl). 2012;90:347–351.
   PubMed Web of Science ®Google Scholar
• Aban C, Leguizamon GF, Cella M, Damiano A, Franchi AM, Farina MG. Differential expression of endocannabinoid system in normal and preeclamptic placentas: effects on nitric oxide synthesis. Placenta. 2013;34:67–74.
   PubMed Web of Science ®Google Scholar
• Cardaropoli S, Rolfo A, Todros T. Helicobacter pylori and pregnancy-related disorders. World J Gastroenterol. 2014;20:654–664.
   PubMed Web of Science ®Google Scholar
• Di Simone N, Tersigni C, Cardaropoli S, Franceschi F, Di Nicuolo F, Castellani R, et al. Helicobacter pylori infection contributes to placental impairment in preeclampsia: basic and clinical evidences. Helicobacter. 2016;22(2).
   Google Scholar
• Tersigni C, Franceschi F, Todros T, Cardaropoli S, Scambia G, Di Simone N. Insights into the role of Helicobacter pylori infection in preeclampsia: from the bench to the bedside. Front Immunol. 2014;5:484.
   PubMed Web of Science ®Google Scholar
• Panayiotides IM. What is the association of cannabis consumption and cardiovascular complications? Subst Abus. 2015;9:1–3.
   PubMed Web of Science ®Google Scholar
• Khan S, Okamoto T, Enomoto K, Sakashita N, Oyama K, Fujii S, et al. Potential association of Helicobacter cinaedi with atrial arrhythmias and atherosclerosis. Microbiol Immunol. 2012;56:145–154.
   PubMed Web of Science ®Google Scholar
• Zhou X, Niu JM, Ji WJ, Zhang Z, Wang PP, Ling XF, Li YM. Precision test for precision medicine: opportunities, challenges and perspectives regarding pre-eclampsia as an intervention window for future cardiovascular disease. Am J Transl Res. 2016;8:1920–1934.
   PubMed Web of Science ®Google Scholar
• Qu B, Su J, Wang Z, Wang Y, Han X, Wang H, et al. Effect of H. pylori Infection on cytokine profiles and oxidative balance in subjects with chronic alcohol ingestion. PLoS ONE. 2015;10:e0129352.
   PubMed Web of Science ®Google Scholar